Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mohamed Ibrahim, Hossam I. Eldesuky & Tamer H. Ibrahim. (2013) Oral olanzapine versus oral ondansetron for prevention of post-operative nausea and vomiting. A randomized, controlled study. Egyptian Journal of Anaesthesia 29:2, pages 89-95.
Read now
Read now
Rudolph M Navari. (2009) Antiemetic control: toward a new standard of care for emetogenic chemotherapy. Expert Opinion on Pharmacotherapy 10:4, pages 629-644.
Read now
Read now
Rudolph M Navari & Paula S Province. (2006) Emerging drugs for chemotherapy-induced emesis. Expert Opinion on Emerging Drugs 11:1, pages 137-151.
Read now
Read now
Articles from other publishers (70)
Masakazu Abe, Takuhiro Yamaguchi, Yukiyoshi Fujita, Tomoyasu Nishimura, Koichi Kitagawa, Naoki Inui, Katsuya Hirano, Yukio Sakata, Hirotoshi Iihara, Yuichi Shibuya, Kenichi Suzuki, Kazuhiko Shibata, Kensuke Hori, Haruko Daga, Toshiaki Nakayama, Yasuhiko Sakata, Takako Yanai Takahashi, Sadamoto Zenda & Hironobu Hashimoto. (2023) Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy. JAMA Network Open 6:5, pages e2310894.
Crossref
Crossref
Daniel S. Childs, David A. HelfinstineJrJr, Lindsey Sangaralingham, Jacob J. Orme, Ciara C. O'Sullivan, Charles L. Loprinzi & Kathryn J. Ruddy. (2022) Slow Uptake of an Effective Therapy: Patterns of Olanzapine Prescribing for Those Receiving Highly Emetogenic Chemotherapy. JCO Oncology Practice 18:12, pages e1953-e1960.
Crossref
Crossref
Ronald Chow, Jørn Herrstedt, Matti Aapro, Leonard Chiu, Henry Lam, Elizabeth Prsic, Michael Lock, Carlo DeAngelis & Rudolph M. Navari. (2021) Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting: a systematic review, meta-analysis, cumulative meta-analysis and fragility assessment of the literature. Supportive Care in Cancer 29:7, pages 3439-3459.
Crossref
Crossref
Sandip Mukhopadhyay, Premnath Dutta, Sanatan Banerjee, Biswamit Bhattacharya, Supreeti Biswas & Rudolf M Navari. (2021) Low-dose olanzapine, sedation and chemotherapy-induced nausea and vomiting: a prospective randomized controlled study. Future Oncology 17:16, pages 2041-2056.
Crossref
Crossref
Jaime B. Hyman, Chang Park, Hung-Mo Lin, Beatriz Cole, Leigh Rosen, Suzanne S. Fenske, Rachel L. Barr Grzesh, Stephanie V. Blank, Sylvie B. Polsky, Matthew Hartnett, Peter J. Taub, Vijay Palvia, Samuel DeMaria & Charles Ascher-Walsh. (2020) Olanzapine for the Prevention of Postdischarge Nausea and Vomiting after Ambulatory Surgery. Anesthesiology 132:6, pages 1419-1428.
Crossref
Crossref
Veerisa Vimolchalao, Siwat Sakdejayont, Ploytuangporn Wongchanapai, Shama Sukprakun, Pattama Angspatt, Wilai Thawinwisan, Piyachut Chenaksara, Virote Sriuranpong, Chanida Vinayanuwatikun, Napa Parinyanitikun, Nattaya Poovorawan & Suebpong Tanasanvimon. (2019) The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy. International Journal of Clinical Oncology 25:2, pages 396-402.
Crossref
Crossref
Eshak Ibrahim Bahbah, Ahmed Ramadan Abdalla, Khalid Abdelshafy, Ahmed Diaa Almohandes, Amr Menshawy, Mohamed Abd Elalem Aziz, Mahmoud Ahmed Ebada, Awad Hegab & Ahmed Negida. (2019) Should Olanzapine be Advocated Over Conventional Anti-Emetics for the Prevention of Chemotherapy-Induced Nausea and Vomiting? An Updated Meta-Analysis of Randomized Control Trials. Current Enzyme Inhibition 15:2, pages 80-90.
Crossref
Crossref
Signe Harder, Mogens Groenvold, Jesper Isaksen, Jarl Sigaard, Karin Bruun Frandsen, Mette Asbjoern Neergaard, Lise Mondrup & Jørn Herrstedt. (2018) Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study. Supportive Care in Cancer 27:8, pages 2849-2856.
Crossref
Crossref
David J. Cangemi & Braden Kuo. (2019) Practical Perspectives in the Treatment of Nausea and Vomiting. Journal of Clinical Gastroenterology 53:3, pages 170-178.
Crossref
Crossref
Bertrand Behm, Carlos Fernandez & Mellar P. Davis. 2019. Textbook of Palliative Care. Textbook of Palliative Care
239
257
.
Rudolph M. Navari. 2019. International Manual of Oncology Practice. International Manual of Oncology Practice
1007
1045
.
Alaa A.M. OsmanMoawia M.A. ElhassanBlala H.A. AbdElrahimFatima H.A. AhmedJihad B.H. YousifMalak A.M. AhmedRomisa H.A. AbdelhafeezUmsalama M.Y. Ahmed. (2018) Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Comparative Study From Sudan. Journal of Global Oncology:4, pages 1-9.
Crossref
Crossref
Florian Slimano, Florence Netzer, Isabelle Borget, François Lemare & Benjamin Besse. (2018) Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy. International Journal of Clinical Pharmacy 40:5, pages 1265-1271.
Crossref
Crossref
Vahé S. Tateosian, Katelynn Champagne & Tong J. Gan. (2018) What is new in the battle against postoperative nausea and vomiting?. Best Practice & Research Clinical Anaesthesiology 32:2, pages 137-148.
Crossref
Crossref
Takako Yanai, Satoru Iwasa, Hironobu Hashimoto, Fumiyoshi Ohyanagi, Tomomi Takiguchi, Koji Takeda, Masahiko Nakao, Hiroshi Sakai, Toshiaki Nakayama, Koichi Minato, Takahiro Arai, Kenichi Suzuki, Yasuhiro Shimada, Kengo Nagashima, Hiroyuki Terakado & Noboru Yamamoto. (2017) A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy. International Journal of Clinical Oncology 23:2, pages 382-388.
Crossref
Crossref
Bertrand Behm, Carlos Fernandez & Mellar P. Davis. 2018. Textbook of Palliative Care. Textbook of Palliative Care
1
19
.
Ting Yang, Qianxin Liu, Min Lu, Lingyue Ma, Ying Zhou & Yimin Cui. (2017) Efficacy of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting: a meta-analysis. British Journal of Clinical Pharmacology 83:7, pages 1369-1379.
Crossref
Crossref
Jukapun Yoodee, Unchalee Permsuwan & Mantiwee Nimworapan. (2017) Efficacy and safety of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 112, pages 113-125.
Crossref
Crossref
William L. Hasler. 2017. Nausea and Vomiting. Nausea and Vomiting
119
137
.
Prashant Singh & Braden Kuo. (2016) Central Aspects of Nausea and Vomiting in GI Disorders. Current Treatment Options in Gastroenterology 14:4, pages 444-451.
Crossref
Crossref
Rudolph M. Navari, Rui Qin, Kathryn J. Ruddy, Heshan Liu, Steven F. Powell, Madhuri Bajaj, Leah Dietrich, David Biggs, Jacqueline M. Lafky & Charles L. Loprinzi. (2016) Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting. New England Journal of Medicine 375:2, pages 134-142.
Crossref
Crossref
Leonard Chiu, Ronald Chow, Marko Popovic, Rudolph M. Navari, Nathan M. Shumway, Nicholas Chiu, Henry Lam, Milica Milakovic, Mark Pasetka, Sherlyn Vuong, Edward Chow & Carlo DeAngelis. (2016) Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis. Supportive Care in Cancer 24:5, pages 2381-2392.
Crossref
Crossref
Ronald Chow, Leonard Chiu, Rudolph Navari, Steven Passik, Nicholas Chiu, Marko Popovic, Henry Lam, Mark Pasetka, Edward Chow & Carlo DeAngelis. (2015) Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review. Supportive Care in Cancer 24:2, pages 1001-1008.
Crossref
Crossref
Masakazu Abe, Yasuyuki Hirashima, Yuka Kasamatsu, Nobuhiro Kado, Satomi Komeda, Shiho Kuji, Aki Tanaka, Nobutaka Takahashi, Munetaka Takekuma, Hanako Hihara, Yoshikazu Ichikawa, Yui Itonaga, Tomoko Hirakawa, Kaei Nasu, Kanoko Miyagi, Junko Murakami & Kimihiko Ito. (2015) Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial. Supportive Care in Cancer 24:2, pages 675-682.
Crossref
Crossref
David L. DeRemer, Amber B. Clemmons, Julianne Orr, Stephen Michael Clark & Arpita Shah Gandhi. (2016) Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:2, pages 218-229.
Crossref
Crossref
Prashant Singh, Sonia S. Yoon & Braden Kuo. (2015) Nausea: a review of pathophysiology and therapeutics. Therapeutic Advances in Gastroenterology 9:1, pages 98-112.
Crossref
Crossref
Govind Babu, Smitha Carol Saldanha, Lakshmaiah Kuntegowdanahalli Chinnagiriyappa, Linu Abraham Jacob, Suresh Babu Mallekavu, Loknatha Dasappa, Pretesh Rohan Kiran, Aparna Sreevatsa, Sandhya Appachu, Vineetha Unnikrishnan & Venugopal Arroju. (2016) The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India. Chemotherapy Research and Practice 2016, pages 1-5.
Crossref
Crossref
Rudolph M. Navari. 2016. Management of Chemotherapy-Induced Nausea and Vomiting. Management of Chemotherapy-Induced Nausea and Vomiting
107
120
.
Rudolph M. Navari. (2015) 5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy. Biochimica et Biophysica Acta (BBA) - Biomembranes 1848:10, pages 2738-2746.
Crossref
Crossref
C. Fonte, S. Fatigoni & F. Roila. (2015) A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients. Critical Reviews in Oncology/Hematology 95:2, pages 214-221.
Crossref
Crossref
J. Liu, L. Tan, H. Zhang, H. Li, X. Liu, Z. Yan, J. Chen, H. Yang & D. Zhang. (2015) QoL evaluation of olanzapine for chemotherapy-induced nausea and vomiting comparing with 5-HT3 receptor antagonist. European Journal of Cancer Care 24:3, pages 436-443.
Crossref
Crossref
Jacqueline Flank, Jennifer Thackray, Danelle Nielson, Amanda August, Tal Schechter, Sarah Alexander, Lillian Sung & L. Lee Dupuis. (2015) Olanzapine for treatment and prevention of acute chemotherapy-induced vomiting in children: A retrospective, multi-center review. Pediatric Blood & Cancer 62:3, pages 496-501.
Crossref
Crossref
. 2015. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
229
415
.
Rudolph M. Navari. 2015. International Manual of Oncology Practice. International Manual of Oncology Practice
779
804
.
Shi-Yong Wang, Zhen-Jun Yang & Lu Zhang. (2014) Olanzapine for Preventing Nausea and Vomiting Induced by Moderately and Highly Emetogenic Chemotherapy. Asian Pacific Journal of Cancer Prevention 15:22, pages 9587-9592.
Crossref
Crossref
Xiao-fei Wang, Yun Feng, Ying Chen, Bei Li Gao & Bao-hui Han. (2014) A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting. Scientific Reports 4:1.
Crossref
Crossref
Christopher M. Hocking & Ganessan Kichenadasse. (2014) Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review. Supportive Care in Cancer 22:4, pages 1143-1151.
Crossref
Crossref
Naomi Mizukami, Masanori Yamauchi, Kazuhiko Koike, Akihiko Watanabe, Koji Ichihara, Naoya Masumori & Michiaki Yamakage. (2014) Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of Pain and Symptom Management 47:3, pages 542-550.
Crossref
Crossref
Howard S. Smith & Andras Laufer. (2014) Opioid induced nausea and vomiting. European Journal of Pharmacology 722, pages 67-78.
Crossref
Crossref
Rudolph M. Navari. (2014) Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting. European Journal of Pharmacology 722, pages 180-186.
Crossref
Crossref
Sierra Vig, Laurel Seibert & Myke R. Green. (2013) Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity. Journal of Cancer Research and Clinical Oncology 140:1, pages 77-82.
Crossref
Crossref
Rudolph M. Navari. (2013) Management of Chemotherapy-Induced Nausea and Vomiting. Drugs 73:3, pages 249-262.
Crossref
Crossref
Eric Prommer. (2012) Olanzapine. American Journal of Hospice and Palliative Medicine® 30:1, pages 75-82.
Crossref
Crossref
Masakazu Abe, Satomi Komeda, Shiho Kuji, Aki Tanaka, Nobutaka Takahashii, Munetaka Takekuma & Yasuyuki Hirashima. (2013) Clinical research of olanzapine for prevention of chemotherapy-induced nausea and vomiting resistant to standard antiemetic treatment for highly emetogenic chemotherapy. Palliative Care Research 8:1, pages 127-134.
Crossref
Crossref
Franziska Jahn, P. Feyer & K. Jordan. (2012) Antiemetische Prophylaxe und Therapie bei chemo- und radiotherapieinduzierter Nausea und Emesis. best practice onkologie 7:3, pages 38-51.
Crossref
Crossref
S. Lorenzen. (2012) Chemotherapy-induced nausea and vomiting ? standards in 2012. memo - Magazine of European Medical Oncology 5:1, pages 47-51.
Crossref
Crossref
Roxana S. Dronca & Charles Loprinzi. 2012. Management of Cancer in the Older Patient. Management of Cancer in the Older Patient
171
181
.
Paul Howard, Robert Twycross, John Shuster, Mary Mihalyo & Andrew Wilcock. (2011) Antipsychotics. Journal of Pain and Symptom Management 41:5, pages 956-965.
Crossref
Crossref
P. Feyer & K. Jordan. (2011) Update and new trends in antiemetic therapy: the continuing need for novel therapies. Annals of Oncology 22:1, pages 30-38.
Crossref
Crossref
Rudolph M. Navari, Paula P. Province & Steven D. Passik. 2011. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures
453
471
.
N. Licup & S. Baumrucker. (2010) Olanzapine for Nausea and Vomiting. American Journal of Hospice and Palliative Medicine 27:6, pages 432-434.
Crossref
Crossref
L. Lee Dupuis & Paul C. Nathan. (2010) Optimizing Emetic Control in Children Receiving Antineoplastic Therapy. Pediatric Drugs 12:1, pages 51-61.
Crossref
Crossref
Yasuhiko Sakata, Kouichi Hiraki, Nobue Uetake, Shinichi Miyamori, Utae Yonezawa, Chie Hamai, Yasuo Iwamoto, Masaaki Noda, Souichi Kitaguchi, Hidetaka Sumiyoshi & Yasuki Tomoda. (2010) Efficacy of Olanzapine against Nausea and Vomiting in Cancer Patients Receiving Chemotherapy. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 36:10, pages 717-722.
Crossref
Crossref
C. Bredin, M.-P. Massoure, D. Corberand & P. Rey. (2010) Complications digestives des chimiothérapies. EMC - Gastro-entérologie 5:4, pages 1-15.
Crossref
Crossref
Flora Hoodin, Felicity W. K. Harper & Donna M. Posluszny. 2010. Allogeneic Stem Cell Transplantation. Allogeneic Stem Cell Transplantation
619
656
.
Lijun Tan, Jiangtao Liu, Xiuli Liu, Jie Chen, Zhijun Yan, Huifen Yang & Daxin Zhang. (2009) Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting. Journal of Experimental & Clinical Cancer Research 28:1.
Crossref
Crossref
Nissar A. Darmani & Andrew P. Ray. (2009) Evidence for a Re-Evaluation of the Neurochemical and Anatomical Bases of Chemotherapy-Induced Vomiting. Chemical Reviews 109:7, pages 3158-3199.
Crossref
Crossref
K. Jordan, F. Müller & H.J. Schmoll. (2009) Neue antiemetische Strategien – nicht nur in der OnkologieNew antiemetic strategies – not only in oncology. Der Internist 50:7, pages 887-894.
Crossref
Crossref
K. Jordan, T. Behlendorf & P. Feyer. (2009) Neue Substanzen in der antiemetischen TherapieNew drugs in antiemetic therapy. Der Onkologe 15:2, pages 121-128.
Crossref
Crossref
Takuya Kitada, Takashi Narimatsu & Seiko Yamaguchi. (2009) Olanzapine as an antiemetic in intractable nausea and anorexia in patients with advanced hepatocellular carcinoma: three case series. Kanzo 50:3, pages 153-158.
Crossref
Crossref
Rudolph M. Navari. (2009) Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting. Drugs 69:5, pages 515-533.
Crossref
Crossref
Lisa Lohr. (2008) Chemotherapy-Induced Nausea and Vomiting. The Cancer Journal 14:2, pages 85-93.
Crossref
Crossref
Michel Beauverd, Sophie Pautex & José Pereira. (2008) Place des neuroleptiques atypiques dans la prise en charge du delirium et des nausées chez le patient palliatif. InfoKara Vol. 22:4, pages 95-103.
Crossref
Crossref
Rudolph M. Navari, Lawrence H. Einhorn, Patrick J. LoehrerSrSr, Steven D. Passik, Jake Vinson, John McClean, Naveed Chowhan, Nasser H. Hanna & Cynthia S. Johnson. (2007) A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study. Supportive Care in Cancer 15:11.
Crossref
Crossref
F. Roila, M. Garassino & S. Fatigoni. (2007) New anti-emetic treatments. Annals of Oncology 18, pages ix43-ix47.
Crossref
Crossref
Karin Jordan, Hans J. Schmoll & Matti S. Aapro. (2007) Comparative activity of antiemetic drugs. Critical Reviews in Oncology/Hematology 61:2, pages 162-175.
Crossref
Crossref
Brigitte Bloechl-Daum, Robert R. Deuson, Panagiotis Mavros, Mogens Hansen & Jørn Herrstedt. (2006) Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment. Journal of Clinical Oncology 24:27, pages 4472-4478.
Crossref
Crossref
. (2016) EAPC Abstracts. Palliative Medicine 20:3, pages 229-379.
Crossref
Crossref
Rudolph M. Navari. (2006) Ondansetron, prochlorperazine, and dexamethasone have similar effects on prevention of delayed chemotherapy-induced nausea and vomiting. Cancer Treatment Reviews 32:1, pages 50-54.
Crossref
Crossref
Rudolph M. Navari, Lawrence H. Einhorn, Steven D. Passik, Patrick J. LoehrerSrSr, Cynthia Johnson, M. L. Mayer, J. McClean, Jake Vinson & W. Pletcher. (2005) A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group study. Supportive Care in Cancer 13:7, pages 529-534.
Crossref
Crossref